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included in their meta-analysis to calculate expected event rates rather than using the event rates from the studies in the meta-analysis itself.
The authors base their analysis on the likelihood ratio (LR) with the justification that this statistic is population independent. LR, like sensitivity and specificity, is theoretically population independent only to the extent that the population is composed of a binary mixture of individuals. In practice, all statistical measures may be population dependent and one cannot assume that results from one population may be reliably extrapolated to another. Expected event rates bifurcated by test result combined with the expected benefit/risk of the intervention are among the most important parameters for clinical decision making.
The most relevant sub-analysis presented by the authors is the one that excluded the surrogate endpoints mentioned above. The authors reported that for this sub-analysis LR+ = 1.79 and LR-= 0.34. Applying these LRs to the SCD annual event rate that the authors derive from SCDHeFT 4 (more recent than MADIT-II 5 data) yields expected annual SCD rates of 5.2% and 1.0%.
These results match well with the actually measured rates of 4.2% and 0.9% in 1004 patients with LVEF <= 0.35 from a recent pooled analysis 6 .
No study has ever demonstrated a benefit for ICD therapy in a patient population with an SCD rate anywhere close to as low a level as 0.9% per year. ICD implantation itself is associated with an in-hospital mortality of approximately 1% and a high complication rate subsequent to implantation 7 . Conversely, patients with a non-negative MTWA test have SCD event rates which are greater than the event rates in the studies for which ICD therapy was demonstrated to provide a mortality benefit. Moreover, ICD therapy has been directly demonstrated to provide a mortality benefit only in patients with a non-negative MTWA result but not in patients with a negative result 8 .
Consistent with other analyses 3 
